- AE
adverse event
- BSC
best supportive care
- CADTH
Canadian Agency for Drugs and Technologies in Health
- CDEC
Canadian Drug Expert Committee
- CDR
CADTH Common Drug Review
- CM
chronic migraine
- CUA
cost-utility analysis
- EM
episodic migraine
- ER
emergency room
- HC
Health Canada
- HDPM
headache days per month
- HIT-6
Headache Impact Test-6
- HTA
health technology assessment
- IBMS
International Burden of Migraine Study
- ICHD
International Classification of Headache Disorders
- ICUR
incremental cost-utility ratio
- INESSS
L’Institut national d’excellence en santé et en services sociaux
- ITT
intention-to-treat
- MSQ
Migraine-Specific Quality of Life Questionnaire
- NICE
National Institute for Health and Care Excellence
- PBAC
Pharmaceutical Benefits Advisory Committee
- PSA
probabilistic sensitivity analysis
- QALY
quality-adjusted life-year
- SMC
Scottish Medicines Consortium
- U
unit
- VAS
visual analogue scale
Publication Details
Copyright
You are permitted to make copies of this document for non-commercial purposes, provided it is not modified when reproduced and appropriate credit is given to CADTH. You may not otherwise copy, modify, translate, post on a website, store electronically, republish, or redistribute any material from this document in any form or by any means without the prior written permission of CADTH.
Please contact CADTH’s Vice-President of Corporate Services at ac.htdac@secivresetaroproc with any inquiries about this notice or other legal matters relating to CADTH’s services.
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
Publisher
Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)
NLM Citation
OnabotulinumtoxinA for Injection (Botox): For the Prophylaxis of Headaches in Adults With Chronic Migraine (≥ 15 Days per Month With Headache Lasting 4 Hours a Day or Longer) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul. ABBREVIATIONS.